1998
On September 29, 1998, the South Korean company "NEXT EYE Co., Ltd." was founded, focusing on the research and manufacturing of industrial automation testing equipment. It became a cooperative manufacturer of semiconductor giants Samsung Group, LG Group for mobile phones and high-end home appliances, and Hyundai Motor Company for Hyundai Motor Group at that time.
2006
AJUIB, a well-known technology capital in South Korea, has invested heavily in NEXTEYE. AJUIB is a top tier venture capital firm in South Korea. Some well-known government agencies, such as the Korea Technology Credit Guarantee Fund (KTAC), KIST, and ETRI, have served as shareholders of KTAC. AJUIB provides comprehensive services to its invested companies from start to finish, including investment, financial credit, management consulting, technical assistance, mergers and acquisitions, and more.
2011
NEXTEYE has been listed on the South Korean Growth Enterprise Market, becoming a unicorn leader in industrial automation testing equipment technology and manufacturing.
2016
Aesthetic Intentional invested 56 billion yuan in NEXTEYE, marking the beginning of NEXTEYE's biotechnology and beauty business;
Ms. Sunny Chen has taken over as the Chairman of NEXTEYE;
NEXTEYE invests 6 billion yuan in NEW&NEW, a well-known South Korean pharmaceutical research and manufacturing company;
2017
NEXTEYE invested heavily and acquired INS KOREA, the largest nail polish R&D and manufacturing factory in South Korea;
NEXTEYE invests heavily in SYMPHONY, a famous plastic surgery hospital in Seoul, South Korea;
2018
Formally launching the distribution and chain business of cosmetics in China;
Acquiring South Korean testing equipment research and development company Mindseye;
INNOMETRY, a subsidiary invested by NEXTEYE, is listed on the Kostak Technology Board.
2019
NEXTEYE invests in the establishment of JDML Cosmetics, a wholly-owned subsidiary in South Korea;
JDML Cosmetic launched VN sunscreen, FHD blood orange facial mask and other online celebrity products, covering duty-free stores in South Korea and sweeping the Chinese market;
2021
NEXTONE, a wholly-owned subsidiary of South Korea, has registered the NEXTSTAR BIO trademark in major global markets;
NEXTONE Bio, a wholly-owned subsidiary of South Korea, has invested in establishing a biotechnology research and development laboratory in California, USA. The laboratory is led by Dr. HONGBING ZHANG, a world-renowned anti-cancer and anti-aging expert from Harvard Medical University;
NEXTEYE has invested heavily in PRP SCIENCE, the only Korean manufacturing company in Asia to obtain official permission for subcutaneous injection of hyaluronic acid into the human body;
2025
NEXTEYE has invested in establishing a wholly-owned subsidiary in South Korea, NEXTONE, and has set up a subsidiary called NEXTSTAR CHINA (Shenzhen) Cross border E-commerce Co., Ltd. in Shenzhen, China; The global operational headquarters is located in Sha Tin District, Hong Kong, and the self built global cross-border e-commerce platform will officially open for operation on June 1, 2025.
